In practice, treating conditions such as headaches, psychological disorders, sleep disorders, gastrointestinal conditions etc., may have several challenges.

In recent years, an age-old treatment has been reinvented as a modern day non-invasive treatment option that has minimal or no significant side-effects: Transcutaneous Vagus Nerve Stimulation (tcVNS).

tcVNS device has been approved (Yuan and Silberstein, 2016b) for acute and prophylactic treatment or adjunctive use:

• primary headaches (cluster headache, migraine, hemicrania continua)
• medication overuse headache (in adults)
• reactive airway conditions (asthma, exercise-induced bronchospasm, COPD)
• epilepsy 
• panic disorder / anxiety
• post-traumatic stress disorder
• major depressive disorder
• obsessive-compulsive disorder
• gastric disorders
• irritable bowel syndrome

While more research is needed to fully understand its potential benefits, early results are promising and suggest that it may be a valuable tool for treating a variety of disorders such as:

• insomnia
• inflammation
• stroke (immediate / post rehab)
• cognitive impairment
• tinnitus
• COVID-19
• rheumatoid arthritis
• autism
• bipolar disorder
• alzheimer’s disease
• obesity
• impaired glucose tolerance
• gastroparesis
• asthma
• fibromyalgia
• traumatic brain injury (TBI)
• concussion
• homeostasis
• cerebellar tremor
• involuntary movement disorders

Please do not hesitate to contact us for reference articles for any of the above-mentioned conditions.